Invited talks

  • 04/04/2020   Targeting Proinflammatory Prostaglandin Receptors for Malignant Gliomas, ASPET Annual Meeting at Experimental Biology, San Diego, CA (Cancelled due to COVID-19)
  • 11/08/2018   Inflammation in epilepsy and glioma: The cart or the horse? 74th Annual American Chemical Society Southwest Regional Meeting, Little Rock, AR
  • 09/25/2018   Inflammation, Epilepsy and Glioma: which is the cart, which the horse? Neuroscience Institute, University of Tennessee Health Science Center, Memphis, TN
  • 03/26/2018   Inflammation, Epilepsy, and Glioma; which is the cart, which is the horse? College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN
  • 01/08/2018   Inflammation in Epilepsy and Glioma: the cart or the horse, Department of Pharmacodynamics, University of Florida College of Pharmacy, Gainesville, FL
  • 06/01/2017   Inflammation, Epilepsy and Glioma: which is the cart, which the horse? (part II), UC Collaborative for Research in Acute Neurological Injuries, Cincinnati, OH
  • 04/27/2017   Inflammation, Epilepsy and Glioma: which is the cart, which the horse? (part I), UC Collaborative for Research in Acute Neurological Injuries, Cincinnati, OH
  • 10/12/2016   Targeting Inflammatory Prostaglandin Signaling for Glioblastoma, UC Brain Tumor Center, Cincinnati, OH
  • 02/19/2016   Inflammation and Epilepsy – mechanisms and opportunities, UC Neuroscience Graduate Program, Cincinnati, OH
  • 09/10/2015   Inflammation and status epilepticus – mechanisms and opportunities, UC Neuroscience Graduate Program, Cincinnati, OH
  • 06/11/2015   Neuroinflammation following status epilepticus: mechanisms and opportunities, UC Epilepsy Center, University of Cincinnati Gardner Neuroscience Institute, Cincinnati, OH
  • 12/05/2014   Neuroinflammation following status epilepticus: mechanisms and opportunities, American Epilepsy Society Annual Meeting, Seattle, WA
  • 08/07/2014   Prostaglandin signaling following status epilepticus: mechanisms and opportunities, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH
  • 06/26/2014   Status epilepticus and neuroinflammation: mechanisms and opportunities, Department of Pharmacology, Penn State College of Medicine, Hershey, PA
  • 04/01/2014   Inflammation and Status Epilepticus: from Characterization to Therapeutics, Department of Pharmacology, University of Florida College of Medicine, Gainesville, FL
  • 03/26/2014   Neuroinflammation in status epilepticus: mechanisms and opportunities, Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL
  • 03/05/2014   Neuroinflammation: mechanisms and opportunities, Center for Pain Research and Innovation, University of North Carolina, Chapel Hill, NC
  • 01/06/2014   Inflammatory prostaglandin signaling following status epilepticus, Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, MS
  • 12/08/2013   Inflammatory prostaglandin signaling after status epilepticus, American Epilepsy Society Annual Meeting, Washington, DC
  • 12/03/2013   Inflammatory prostaglandin signaling following status epilepticus, Department of Pharmacology, Baylor College of Medicine, Houston, TX
  • 11/25/2013   Inflammatory prostaglandin signaling following status epilepticus, Department of Health & Human Physiology, College of Liberal Arts & Sciences, University of Iowa, Iowa City, IA
  • 10/15/2013   Inhibiting inflammatory prostaglandin signaling after status epilepticus reduces brain injury, World Drug Discovery Online Conference, Target Meeting
  • 05/29/2013   Targeting inflammation by highly potent compounds to treat CNS conditions: implications from preclinical studies on status epilepticus. World HPAPI Summit, Philadelphia, PA
  • 05/16/2013   Inhibiting inflammatory prostaglandin signaling after status epilepticus reduces brain injury and inflammation, Postdoctoral Fellow Research Symposium, Emory University, Atlanta, GA
  • 06/28/2012   Novel Potent Small Molecules for Inflammatory Disease: Harnessing the Power of Prostaglandin Receptors for CNS Conditions. World HPAPI Summit, Philadelphia, PA